DiGeorge Syndrome Critical Region Gene 8 (DGCR8) Peptide
DGCR8
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN937407
382,12 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 20 à 27 jours ouvrables
Aperçu rapide pour DiGeorge Syndrome Critical Region Gene 8 (DGCR8) Peptide (ABIN937407)
Antigène
DGCR8
(DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- DKKDEENELD QEKRVEYAVL DELEDFTDNL ELDEEGAGGF TAKAIVQRDR
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DGCR8 antibody,
Alternative Names: DGCR8 control peptide, DGCR8 antibody Blocking Peptide, Anti-DGCR8 Blocking Peptide, Digeorge Syndrome Critical Region Gene 8 Blocking Peptide, C22orf12 Blocking Peptide, DGCRK6 Blocking Peptide, Gy1 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
-
Sujet
- DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
-
Poids moléculaire
- 85 kDa
Antigène
-
Vous êtes ici:
